Alphatec Hlds (ATEC) Stock Forecast & Price Target

Alphatec Holdings is facing near-term challenges in meeting revenue expectations due to weakness in the EOS franchise and unfavorable surgical case mix, but with a >20% surgeon growth supporting strong procedure volumes and continued leverage of its business model, the company's balance sheet and leverage position are expected to improve. The high-risk factors, such as poor sales execution and competition in the spine market, could impact the company's profitability. However, the Q1 results, including a 71.0% gross margin and disciplined operating expenses, were better than expected, and Alphatec Holdings' outlook for adjusted EBITDA and free cash flow for the full year remains unchanged.

Alphatec Holdings is facing challenges in its key EOS imaging business, with lower than expected revenues and a decrease of 18% YoY. Management has acknowledged sales execution struggles and has adjusted their 2026 revenue guidance accordingly. Despite these challenges, Alphatec Holdings believes it can maintain profitability and has reiterated its adjusted EBITDA guidance of $134M and FCF guidance of $20M for 2026. Concerns for investors include slower EOS growth, missed revenue due to EOS weakness, and challenges with coordinating installations and revenue recognition. The stock has taken a significant hit in the aftermarket, but the fundamentals of the business remain intact. Thus, the negative outlook is tied to the current challenges and potential transient issues, rather than the long-term potential of the company.